Intellia Therapeutics Inc buy Citigroup Inc.
Start price
28.04.26
/
50%
€11.14
Target price
28.04.27
-
Performance (%)
8.26%
Price
29.05.26
€12.06
Summary
This prediction is currently active. With a performance of 8.26%, the BUY prediction by Citigroup_Inc_ for Intellia Therapeutics Inc is trending in the right direction. This prediction currently runs until 28.04.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 11.050% | 11.050% |
| iShares Core DAX® | 1.051% | 4.896% |
| iShares Nasdaq 100 | 2.414% | 11.649% |
| iShares Nikkei 225® | 4.165% | 13.991% |
| iShares S&P 500 | 0.963% | 6.365% |
Comments by Citigroup_Inc_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its "outperform" rating reaffirmed by Citigroup Inc..
Ratings data for NTLA provided by MarketBeat